Epitalon: what the research shows
A four-amino-acid peptide studied for aging and telomeres, mostly in cells and animals.
Also known as Epithalon
At a glance
Not approved. Most research is lab and animal work.
What is Epitalon?
Epitalon is a lab-made peptide of four building blocks (alanine, glutamic acid, aspartic acid and glycine), based on an extract from the pineal gland. It was developed by Russian researchers.
How does Epitalon work?
Lab studies suggest it may switch on telomerase, an enzyme that rebuilds telomeres. Telomeres are the protective caps on the ends of our chromosomes, and they get shorter as we age.
What does the research show?
- A 2025 study found it lengthened telomeres in human cells grown in the lab.
- Much of the earlier research comes from one Russian group, and good human trials are lacking.
- FDA advisers reviewed it for insomnia in July 2026 as a possible compounding ingredient.
Known risks and side effects
- Its effects and safety in people are unknown.
Is Epitalon approved?
Mostly studied in cells and animals, with little or no proper testing in people.
Not approved. Most research is lab and animal work.
From the community
Watch: Epitalon and related science
Start with the compound discussion, then use the background lesson to understand its biology. Each card explains its connection. Recordings may predate later findings or regulatory changes.
U.S. Food and Drug Administration
FDA peptide compounding meeting: July 24, 2026
Full meeting covering DSIP (emideltide), Semax and Epitalon. Advisory discussion is not drug approval.
Official FDA advisory committee recording
Official regulatory recording
The original July 24, 2026 FDA discussion of DSIP, Semax and Epitalon; it documents an advisory review.
TED
The science of cells that never get old
The discovery and biology of telomeres. This is not a trial of epitalon or any anti-ageing product.
Elizabeth Blackburn, PhD · Nobel laureate in telomere research
Related biology
Background on telomeres and cellular ageing for understanding Epitalon. It does not demonstrate benefits of this compound or formulation.
National Institute of Mental Health
Clinical research: risks and benefits
Why an experimental treatment can involve uncertainty even when its scientific rationale sounds promising.
NIMH · US National Institutes of Health
Research skills
Helps you judge the study design or uncertainty in Epitalon research; it is not a trial of the compound.
Sources and references
- Overview of Epitalon, a highly bioactive pineal tetrapeptideAraj et al. · International Journal of Molecular Sciences · 2025
- Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activityAl-Dulaimi et al. · Biogerontology · 2025
- FDA Pharmacy Compounding Advisory Committee, July 23–24, 2026US Food and Drug Administration · meeting page
VETUD Learn explains published research in plain language. It is general information, not medical advice. Talk to a doctor before starting, stopping or changing any treatment.
In the research shop
Check the catalog for related laboratory research materials. These products are separate from the approved medicines and clinical trial formulations discussed here.
Checking regional availability…
